{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:04:37Z","timestamp":1784657077846,"version":"3.55.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science and Technology Research Project of Jiangxi Provincial Department of Education","award":["GJJ2203544"],"award-info":[{"award-number":["GJJ2203544"]}]},{"name":"Jiangxi Children\u2019s Medical Center","award":["2024B004"],"award-info":[{"award-number":["2024B004"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Wilms tumor (WT) is a prevalent pediatric renal malignancy, yet its molecular mechanisms remain poorly defined. Identifying key prognostic genes and understanding their functional roles is critical for improving clinical management. This study aimed to identify prognostic genes in WT and to investigate whether ATP5F1A functions as a candidate downstream effector in a CDCA8-associated regulatory axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Differentially expressed genes (DEGs) were identified by analyzing RNA-seq datasets (GSE11151, GSE73209), comparing WT tissues with normal kidney samples. Functional enrichment was performed using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. A protein-protein interaction (PPI) network was constructed, and hub genes were identified using Cytoscape. Prognostic significance was assessed through univariate and multivariate Cox regression analyses, and a risk prediction model was developed. External expression validation of candidate hub genes was performed using GSE11024 and GSE110696. CDCA8\u2019s functional role in WT was validated by gene knockdown and overexpression experiments. Co-immunoprecipitation (Co-IP) and ubiquitination assays were conducted to explore the interaction between CDCA8 and ATP5F1A.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 987 DEGs were identified, with six hub genes\u2014BUB1B, CDC45, CDCA8, KIF15, NDC80, and TOP2A\u2014were identified. The exploratory risk score model stratified overall survival in the TARGET-WT cohort (HR\u2009=\u20092.973, Log-rank p\u2009=\u20090.000252), although time-dependent AUC values indicated modest discriminatory performance. CDCA8 was upregulated in WT tissues and associated with worse survival outcomes (HR\u2009=\u20092.03, p\u2009=\u20090.011). Functional assays suggested that CDCA8 knockdown suppressed malignant phenotypes in WiT49 cells. Mechanistically, CDCA8 knockdown reduced ATP5F1A protein levels without altering ATP5F1A mRNA expression, and this reduction was partially rescued by MG132. CDCA8 depletion was also associated with increased ATP5F1A ubiquitination, supporting a role for CDCA8 in maintaining ATP5F1A protein stability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings suggest that CDCA8 may contribute to Wilms tumor cell phenotypes partly by maintaining ATP5F1A protein stability, providing preliminary evidence for a CDCA8-ATP5F1A regulatory axis in WT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0353696","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:30:09Z","timestamp":1784655009000},"page":"e0353696","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["CDCA8 regulates ATP5F1A protein stability and malignant phenotypes in wilms tumor cells: Prognostic implications and mechanistic insights"],"prefix":"10.1371","volume":"21","author":[{"given":"Qiang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3542-7079","authenticated-orcid":true,"given":"Linshan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"1","key":"pone.0353696.ref001","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-021-00308-8","article-title":"Wilms tumour","volume":"7","author":"F Spreafico","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"pone.0353696.ref002","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41581-019-0112-0","article-title":"The genetic changes of Wilms tumour","volume":"15","author":"TD Treger","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"pone.0353696.ref003","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41585-018-0100-3","article-title":"The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol","volume":"15","author":"GM Vujani\u0107","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"22","key":"pone.0353696.ref004","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1158\/1078-0432.CCR-16-0985","article-title":"Significance of TP53 mutation in wilms tumors with diffuse anaplasia: A report from the Children\u2019s Oncology Group","volume":"22","author":"AHAG Ooms","year":"2016","journal-title":"Clin Cancer Res"},{"key":"pone.0353696.ref005","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddaa091","article-title":"Recent advances in Wilms\u2019 tumor predisposition","volume":"29","author":"JL Maciaszek","year":"2020","journal-title":"Hum Mol Genet"},{"issue":"5","key":"pone.0353696.ref006","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/cas.12910","article-title":"Genetic variation frequencies in Wilms\u2019 tumor: A meta-analysis and systematic review","volume":"107","author":"C Deng","year":"2016","journal-title":"Cancer Sci"},{"issue":"1","key":"pone.0353696.ref007","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12885-019-5609-1","article-title":"miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI\/SMAD2\/3 and IGF-1R\/AKT signaling pathways in Wilms\u2019 tumor","volume":"19","author":"Z Liu","year":"2019","journal-title":"BMC Cancer"},{"key":"pone.0353696.ref008","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ebiom.2016.05.029","article-title":"Intra-tumor genetic heterogeneity in wilms tumor: Clonal evolution and clinical implications","volume":"9","author":"GD Cresswell","year":"2016","journal-title":"EBioMedicine"},{"issue":"10","key":"pone.0353696.ref009","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41419-023-06189-x","article-title":"CDCA8 promotes bladder cancer survival by stabilizing HIF1\u03b1 expression under hypoxia","volume":"14","author":"Q Zhou","year":"2023","journal-title":"Cell Death Dis"},{"issue":"11","key":"pone.0353696.ref010","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41388-022-02208-x","article-title":"Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer","volume":"41","author":"Y Yi","year":"2022","journal-title":"Oncogene"},{"issue":"1","key":"pone.0353696.ref011","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12935-021-01850-x","article-title":"CDCA8 as an independent predictor for a poor prognosis in liver cancer","volume":"21","author":"Y Shuai","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"2","key":"pone.0353696.ref012","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cell.2018.07.032","article-title":"Microbial siderophore enterobactin promotes mitochondrial iron uptake and development of the host via interaction with ATP synthase","volume":"175","author":"B Qi","year":"2018","journal-title":"Cell"},{"key":"pone.0353696.ref013","article-title":"DAVID: A web server for functional enrichment analysis and functional annotation of gene lists (2021 update","volume":"50","author":"BT Sherman","year":"2022","journal-title":"). Nucleic Acids Res"},{"issue":"6","key":"pone.0353696.ref014","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"A Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"pone.0353696.ref015","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: Quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"D Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pone.0353696.ref016","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1186\/s12885-024-12541-x","article-title":"Screening of potential hub genes involved in Kidney Wilms tumor via bioinformatics analysis and experimental validation","volume":"24","author":"Q Zeng","year":"2024","journal-title":"BMC Cancer"},{"issue":"11","key":"pone.0353696.ref017","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"3","key":"pone.0353696.ref018","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jpedsurg.2018.09.005","article-title":"Update on Wilms tumor","volume":"54","author":"JH Aldrink","year":"2019","journal-title":"J Pediatr Surg"},{"issue":"16","key":"pone.0353696.ref019","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2017.77.1931","article-title":"Treatment of Stage IV favorable histology wilms tumor with lung metastases: A report from the Children\u2019s Oncology Group AREN0533 Study","volume":"36","author":"DB Dix","year":"2018","journal-title":"J Clin Oncol"},{"issue":"8","key":"pone.0353696.ref020","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/cncr.34107","article-title":"Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002-2020)","volume":"128","author":"Renal Tumour Special Interest Group of the Children\u2019s Cancer and Leukaemia Group","year":"2022","journal-title":"Cancer"},{"issue":"3","key":"pone.0353696.ref021","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2017.73.7999","article-title":"Outcome and prognostic factors in stage III favorable-histology wilms tumor: A report from the Children\u2019s Oncology Group Study AREN0532","volume":"36","author":"CV Fernandez","year":"2018","journal-title":"J Clin Oncol"},{"issue":"8","key":"pone.0353696.ref022","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1200\/JCO.2004.08.008","article-title":"The treatment of stages I-IV favorable histology Wilms\u2019 tumor","volume":"22","author":"DM Green","year":"2004","journal-title":"J Clin Oncol"},{"issue":"12","key":"pone.0353696.ref023","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1073\/pnas.90.12.5828","article-title":"Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product","volume":"90","author":"H Werner","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0353696.ref024","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.canlet.2019.05.013","article-title":"Origins of DNA methylation defects in Wilms tumors","volume":"457","author":"Z Anvar","year":"2019","journal-title":"Cancer Lett"},{"issue":"1","key":"pone.0353696.ref025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/path.5171","article-title":"The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis","volume":"247","author":"L Holmquist Mengelbier","year":"2019","journal-title":"J Pathol"},{"issue":"2","key":"pone.0353696.ref026","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2007.11.046","article-title":"Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment","volume":"132","author":"N Jelluma","year":"2008","journal-title":"Cell"},{"issue":"2","key":"pone.0353696.ref027","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2007.07.045","article-title":"Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together","volume":"131","author":"AA Jeyaprakash","year":"2007","journal-title":"Cell"},{"issue":"2","key":"pone.0353696.ref028","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1083\/jcb.200404001","article-title":"Borealin","volume":"166","author":"R Gassmann","year":"2004","journal-title":"The Journal of Cell Biology"},{"issue":"1","key":"pone.0353696.ref029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40164-022-00366-y","article-title":"CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK\/ERK pathway","volume":"12","author":"E Chen","year":"2023","journal-title":"Exp Hematol Oncol"},{"issue":"21","key":"pone.0353696.ref030","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.3390\/cancers14215434","article-title":"CDCA8\/SNAI2 complex activates CD44 to promote proliferation and invasion of pancreatic ductal adenocarcinoma","volume":"14","author":"J Gu","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0353696.ref031","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41419-021-03405-4","article-title":"Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma","volume":"12","author":"X Wang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"pone.0353696.ref032","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1038\/s41467-018-07232-8","article-title":"Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas","volume":"9","author":"SR Rosario","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"pone.0353696.ref033","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg\u2019s contributions to current concepts of cancer metabolism","volume":"11","author":"WH Koppenol","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"pone.0353696.ref034","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1080\/15548627.2022.2103961","article-title":"TNK2\/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability","volume":"19","author":"S Chouhan","year":"2023","journal-title":"Autophagy"},{"key":"pone.0353696.ref035","article-title":"Chimeric SFT2D2\u2010TBX19 promotes prostate cancer progression by encoding TBX19\u2010202 protein and stabilizing mitochondrial ATP synthase through ATP5F1A phosphorylation","author":"C Hu","year":"2024","journal-title":"Advanced Science"},{"issue":"20","key":"pone.0353696.ref036","article-title":"Identification and characterization of the wilms tumor cancer stem cell","volume":"10","author":"A Petrosyan","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"15","key":"pone.0353696.ref037","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127098","article-title":"Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms\u2019 tumor","volume":"4","author":"MV Ortiz","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"pone.0353696.ref038","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/diagnostics12010157","article-title":"A metabonomic view on wilms tumor by high-resolution magic-angle spinning nuclear magnetic resonance spectroscopy","volume":"12","author":"L Tasic","year":"2022","journal-title":"Diagnostics (Basel)"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:30:16Z","timestamp":1784655016000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353696"}},"subtitle":[],"editor":[{"given":"Eric A.","family":"Shelden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":38,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0353696","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}